|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02160 MP CARDIOFLOW-B
Nominal 
2.810 -0.160 (-5.387%) | 2025/12 - Final USD(K$) | %Chg (Compare to Final) | 2024/12 USD(K$) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Turnover | 57,044 | 12.280% | 50,805 | 336,215 | 251,026 | 200,813 |
| Cost of Sales | (19,982) | 28.866% | (15,506) | (106,284) | (88,896) | (82,112) |
| Gross Profit | 37,062 | 4.994% | 35,299 | 229,931 | 162,130 | 118,701 |
| 2025/12 - Final USD(K$) | %Chg (Compare to Final) | 2024/12 USD(K$) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | 637 | -95.628% | 14,569 | (131,508) | (84,708) | 23,419 | |
| Profit / (Loss) on Disposal | 3,771 | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | (7,210) | -16.792% | (8,665) | (64,457) | (69,309) | (3,512) | |
| Profit / (Loss) before Taxation | (18,035) | 177.419% | (6,501) | (463,582) | (451,299) | (182,651) | |
| Taxation | (789) | -19.817% | (984) | (7,952) | (3,096) | (613) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 5 | -99.069% | 537 | 0 | 0 | 0 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (18,819) | 170.855% | (6,948) | (471,534) | (454,395) | (183,264) | |
| 2025/12 - Final USD(K$) | %Chg (Compare to Final) | 2024/12 USD(K$) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Net Finance Costs / (Income) | (5,495) | -45.616% | (10,104) | (82,397) | (33,231) | (4,810) |
| Depreciation & Amortisation | 21,729 | 12.173% | 19,371 | 73,618 | 78,215 | 44,423 |
| Directors' Emoluments | -- | -- | -- | 14,124 | 9,296 | 10,527 |
| 2025/12 - Final | %Chg (Compare to Final) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2025/12 - Final | %Chg (Compare to Final) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| EPS (cts) | -4.000 | 300.000% | -1.000 | -100.000 | -95.000 | -40.000 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | -- | (0.088) | (0.077) | (0.069) |
| NBV per share ($) | 0.201 | -- | 0.631 | 4.839138 | 5.71456 | 6.441422 |
| Remarks: | Real time quote last updated: 09/04/2026 18:00 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K$) | USD -18,819 |
| %Change | 170.855% |
| EPS / (LPS) | USD -0.040 |
| NBV Per Share ($) | USD 0.201 |